1776 Wealth LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

1776 Wealth LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,803 shares of the healthcare conglomerate’s stock after selling 104 shares during the period. 1776 Wealth LLC’s holdings in UnitedHealth Group were worth $1,054,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. Evergreen Wealth Management LLC increased its stake in UnitedHealth Group by 28.4% in the third quarter. Evergreen Wealth Management LLC now owns 2,609 shares of the healthcare conglomerate’s stock valued at $1,525,000 after acquiring an additional 577 shares during the last quarter. KPP Advisory Services LLC increased its stake in shares of UnitedHealth Group by 1.2% in the third quarter. KPP Advisory Services LLC now owns 3,502 shares of the healthcare conglomerate’s stock worth $2,048,000 after buying an additional 42 shares during the period. Maxwell Wealth Strategies Inc. lifted its holdings in UnitedHealth Group by 26.2% in the 3rd quarter. Maxwell Wealth Strategies Inc. now owns 3,872 shares of the healthcare conglomerate’s stock worth $2,196,000 after buying an additional 804 shares during the period. Natixis Advisors LLC boosted its stake in shares of UnitedHealth Group by 11.0% during the 3rd quarter. Natixis Advisors LLC now owns 742,935 shares of the healthcare conglomerate’s stock valued at $434,380,000 after purchasing an additional 73,515 shares in the last quarter. Finally, Evolution Wealth Advisors LLC bought a new position in UnitedHealth Group in the third quarter worth $241,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH traded down $0.92 during trading on Friday, reaching $592.23. The company’s stock had a trading volume of 3,423,919 shares, compared to its average volume of 3,888,996. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $545.02 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company’s fifty day moving average price is $582.84 and its 200-day moving average price is $549.06.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the business earned $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is currently 54.72%.

Wall Street Analyst Weigh In

Several analysts recently commented on UNH shares. Cantor Fitzgerald increased their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Barclays decreased their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.